Indraprastha Medical Corporation Complete Financial Statements

INDRAMEDCO • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015

Complete Financial Data Export

Export complete financial statements for Indraprastha Medical Corporation (INDRAMEDCO). Downloads include all available records across all periods. For market performance, see the INDRAMEDCO stock price today .

Profitability Ratios

Net Profit Margin 11.68% 2025 data
EBITDA Margin 19.36% 2025 data
Operating Margin 18.00% 2025 data
Return on Assets 18.90% 2025 data
Return on Equity 26.97% 2025 data

Balance Sheet Ratios

Current Ratio 5.67 2025 data
Debt to Equity 1.43 2025 data
Equity Ratio 70.07% 2025 data
Asset Turnover 1.62 2025 data

Year-over-Year Growth Analysis

Comparing March 2025 vs Period
Revenue Growth
+3.8%
Year-over-Year
Net Profit Growth
+8.7%
Year-over-Year
EBITDA Growth
+6.4%
Year-over-Year
Expense Growth
+3.1%
Year-over-Year
Assets Growth
+17.8%
Year-over-Year
Equity Growth
+24.9%
Year-over-Year
Liabilities Growth
+17.8%
Year-over-Year
Operating Cash Flow Growth
-21.5%
Year-over-Year
Investing Cash Flow Growth
+29.7%
Year-over-Year
Financing Cash Flow Growth
-43.8%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 1,431 1,379 1,262 1,109 891 614 832 789 754 766 758 715
Expenses 1,147 1,112 1,051 948 774 573 744 707 680 687 676 630
EBITDA 284 267 210 161 117 41 87 81 74 79 82 86
Operating Profit Margin % 18.00% 18.00% 16.00% 14.00% 13.00% 7.00% 10.00% 10.00% 10.00% 10.00% 11.00% 12.00%
Depreciation 43 44 40 39 35 33 33 30 31 31 35 28
Interest 6 6 4 4 3 3 6 7 9 8 7 8
Profit Before Tax 234 216 166 117 79 4 48 45 34 41 39 50
Tax 63 55 42 31 21 2 5 16 13 15 14 17
Net Profit 175 161 124 86 59 2 44 28 21 26 24 33
Earnings Per Share (₹) 19.10 17.56 13.52 9.40 6.39 0.25 4.76 3.10 2.30 2.86 2.67 3.54

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 852 723 555 462 432 449 422 432 458 461 442
Current Assets 431 308 223 157 141 142 136 133 158 152 149
Fixed Assets 328 347 275 277 283 303 280 294 296 301 286
Capital Work in Progress 33 1 3 0 3 0 1 0 0 3 3
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 491 376 278 185 145 146 141 138 163 157 153
LIABILITIES
Total Liabilities 852 723 555 462 432 449 422 432 458 461 442
Current Liabilities 76 80 46 43 43 42 54 62 42 46 53
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 597 478 380 325 273 268 244 232 231 224 195
Share Capital 92 92 92 92 92 92 92 92 92 92 92
Reserves & Surplus 505 386 288 234 181 176 152 141 139 132 103

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 157 200 145 94 27 86 75 48 28 62 64
Investing Activities -111 -158 -108 -74 -19 -40 -17 -30 -22 -33 -29
Financing Activities -46 -32 -26 -3 -3 -43 -44 -17 -5 -30 -35
Net Cash Flow 0 9 11 17 5 4 14 1 0 -1 0